These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16954719)

  • 1. Reciprocity and post-trial access for participants in antiretroviral therapy trials.
    Merritt M; Grady C
    AIDS; 2006 Sep; 20(14):1791-4. PubMed ID: 16954719
    [No Abstract]   [Full Text] [Related]  

  • 2. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 4. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials.
    Haire B; Jordens C
    Dev World Bioeth; 2015 Aug; 15(2):85-97. PubMed ID: 26193849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standards of care in the antiretroviral rollout world.
    Singh JA
    Lancet; 2004 Sep 11-17; 364(9438):920-2. PubMed ID: 15364176
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating the number of antiretroviral treatment facilities based on the Wilson-Blower method.
    Malangu N
    PLoS Med; 2005 Aug; 2(8):e270. PubMed ID: 16120012
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment needs in HIV prevention trials: using beneficence to clarify sponsor-investigator responsibilities.
    Stobie M; Slack C
    Dev World Bioeth; 2010 Dec; 10(3):150-7. PubMed ID: 20002648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation of a drug fund for post-clinical trial access to antiretrovirals.
    Ananworanich J; Cheunyam T; Teeratakulpisarn S; Boyd MA; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
    Lancet; 2004 Jul 3-9; 364(9428):101-2. PubMed ID: 15234863
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethics of research: the freedom to withdraw].
    de Cenival M
    Bull Soc Pathol Exot; 2008 Apr; 101(2):98-101. PubMed ID: 18543700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV treatment in times of civil strife: serious threats to antiretroviral drug access in the Kibera slum following the Kenyan elections.
    Unge C; Södergård B; Thorson A; Ragnarsson A; Carter J; Ilako F; Waweru M; Ekström AM
    AIDS; 2008 Aug; 22(13):1693-4. PubMed ID: 18670238
    [No Abstract]   [Full Text] [Related]  

  • 11. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: a qualitative study.
    Olupot-Olupot P; Katawera A; Cooper C; Small W; Anema A; Mills E
    AIDS; 2008 Sep; 22(14):1882-4. PubMed ID: 18753867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-trial access to antiretrovirals: who owes what to whom?
    Millum J
    Bioethics; 2011 Mar; 25(3):145-54. PubMed ID: 19594728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 16. Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes.
    Myer L; Rebe K; Morroni C
    Trop Med Int Health; 2007 Dec; 12(12):1484-9. PubMed ID: 18076556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case study of the provision of antiretroviral therapy for refugees in Tanzania.
    Stephen H; Roberts B
    Med Confl Surviv; 2009; 25(2):134-47. PubMed ID: 19655639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community perspectives on care options for HIV prevention trial participants.
    MacQueen KM; Namey E; Chilongozi DA; Mtweve SP; Mlingo M; Morar N; Reid C; Ristow A; Sahay S;
    AIDS Care; 2007 Apr; 19(4):554-60. PubMed ID: 17453597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darunavir: after multiple antiretroviral treatment failure: another option.
    Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid antiretroviral therapy scale-up in Hubei Province, China.
    Sherer R; Gui X; Zhan F; Teter C; Ping DL; Wykoff RF
    Health Aff (Millwood); 2008; 27(4):1140-7. PubMed ID: 18607048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.